Muscle Invasive Bladder Cancer

Also known as: Muscle-invasive Bladder Cancer

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB18442	ABSK-091	1	Active Not Recruiting	1
DB11740	Adavosertib	1	Active Not Recruiting	1
DB14825	Danvatirsen	1	Active Not Recruiting	1
DB11714	Durvalumab	1	Active Not Recruiting	1
DB11714	Durvalumab	1	Completed	1
DB09074	Olaparib	1	Active Not Recruiting	1
DB15088	Oleclumab	1	Completed	1
DB11689	Selumetinib	1	Active Not Recruiting	1
DB11925	Vistusertib	1	Active Not Recruiting	1
DB14922	Tislelizumab	1 / 2	Recruiting	1
DB11945	Avelumab	2	Recruiting	1
DB00515	Cisplatin	2	Completed	3
DB17208	Disitamab vedotin	2	Recruiting	1
DB00997	Doxorubicin	2	Completed	2
DB00997	Doxorubicin	2	Unknown Status	1
DB11714	Durvalumab	2	Terminated	1
DB11717	Epacadostat	2	Withdrawn	1
DB00441	Gemcitabine	2	Completed	1
DB00563	Methotrexate	2	Completed	2
DB09035	Nivolumab	2	Completed	1
DB01229	Paclitaxel	2	Active Not Recruiting	1
DB00019	Pegfilgrastim	2	Completed	1
DB09037	Pembrolizumab	2	Withdrawn	1
DB12257	Platinum	2	Completed	1
DB12332	Rucaparib	2	Terminated	1
DB14922	Tislelizumab	2	Active Not Recruiting	1
DB15043	Toripalimab	2	Recruiting	2
DB11771	Tremelimumab	2	Terminated	1
DB00570	Vinblastine	2	Completed	2
DB11595	Atezolizumab	3	Recruiting	1
DB15140	Bempegaldesleukin	3	Completed	1
DB00515	Cisplatin	3	Active Not Recruiting	3
DB11714	Durvalumab	3	Active Not Recruiting	1
DB11714	Durvalumab	3	Recruiting	1
DB13007	Enfortumab vedotin	3	Active Not Recruiting	1
DB13007	Enfortumab vedotin	3	Recruiting	1
DB00441	Gemcitabine	3	Active Not Recruiting	3
DB09035	Nivolumab	3	Active Not Recruiting	1
DB09035	Nivolumab	3	Completed	1
DB09037	Pembrolizumab	3	Active Not Recruiting	1
DB11771	Tremelimumab	3	Recruiting	1